4/22/2022China's New Regulations on Human Genetic Resources Set to Speed Up R&D...

4/21/2022CDE Solicits Comments on Two Draft Documents on Pediatric Drug Informa...

4/21/2022CDE Issues the Technical Guidelines for Adverse Drug Reaction Data Sum...

4/21/2022ATUM Accelerates Entry of Bioengineering Solutions into China

4/21/2022Legend Makes $50M Milestone under J&J Partnership Deal for Anticancer...

4/20/2022Chugai Pharma Loses China's First Drug Patent Linkage Lawsuit

4/20/2022Roche Partners with Teva to Improve Lymphoma Treatments in China

4/20/2022Joseph Romanelli Returns to Merck to Lead Human Health International A...

4/20/2022I-Mab Reportedly Weighing Options Including Sale: Bloomberg

4/20/2022PharmaDJ's China Biotech Fundraising Tracker: March 2022

4/20/2022China Commercial Health Insurance Opportunities

4/19/2022NMPA Withdraws Approvals of 223 Domestic and Foreign Drug Products

4/19/202234 HK-Listed Chinese Biopharma Firms Saw Sharp Revenue Growth in 2021 ...

4/18/2022Senior Health Official under Investigation for Corruption

4/18/2022VectorBuilder to Build $500M Gene Therapy Manufacturing Facility in Ch...

4/18/2022CDE Solicits Comments on the Draft Technical Guidelines for Drug Clini...

4/18/2022BioBAY Suzhou - China's Biotechnology Megahub

4/17/2022666 White-listed Manufacturing Enterprises Including Nearly 100 Pharma...

4/16/2022Opportunities and Challenges in China for Developing Oncology Drugs fo...

4/15/2022NMPA Issues the Guidelines for Pharmacovigilance Inspections

4/15/2022Drug R&D and Product Registration News Digest April 2022 (2)

4/14/2022Lenz and Ji Xing Announce an Exclusive Greater China License Agreement

4/14/2022Bayer Receives Chinese Approval for Its Cancer Drug Vitrakvi (larotrec...

4/14/2022PhIIC: Chinese Retail Biologics Sales Led by Anti-tumor Drugs in 2021

4/14/2022One to Watch: China's Cell and Gene Therapies Industry (PharmExec)

4/13/2022China Meheco to Distribute Ascletis's Ritonavir Tablets in Mainland Ch...

4/13/2022Prevalence and Risk of Atrial Fibrillation in China: A National Cross-...

4/13/2022SEC Adds Another 12 Chinese Companies to Its Watchlist under the HFCAA

4/12/2022Chinese Pharma Foreign Trade Up 1.9% in 2021 with Sharply Surging West...

4/12/2022NMPA Issues the Measures for Drug Annual Reports

Page:183/814 Total number of articles:24420: [First][<<] [181] [182] [183] [184] [185] [>>] [End]